Abstract
Asthma is a multifactorial, reversible, obstructive lung disease that manifests airway inflammation as well as airway hyperreactivity. In addition to IgE-mediated respiratory reactions, the pathophysiology of asthma can be triggered by both viral respiratory and bacterial sinopulmonary infections. Even though most asthma patients do not manifest undue susceptibility to infection, a subset of asthma patients with recurrent sinopulmonary as well as upperrespiratory infections may have an associated immune deficiency syndrome. In a subset of these patients, deficiencies of serum IgG subclasses have also been described in the presence of low-normal or normal serum IgG and also deficient serum IgA. In addition to the usual asthma therapy with β2 agonist and theophylline bronchodilators as well as cromolyn and steroids, many of these immunodeficiency patients will benefit from iv γ-globulin therapy. However, we suggest that an inability to synthesize specific serum antibody to injected vaccines or immunogens be a prerequisite before initiating iv γ-globulin therapy. The clinician should not rely on serum IgG subclass levels alone as a criterion for initiation of passive immune globulin therapy.
There may be another cohort of asthma patients who could benefit from iv γ-globulin therapy. In a small open-label pilot study severe steroid-dependent asthma patients who were not immunodeficient and did not have undue susceptibility to infection were treated with iv γ-globulin with a very large dosage protocol of 2000 mg/kg monthly. These patients’ asthms symptoms improved, their pulmonary functions improved, and they were able to reduce their steropd medication.
Similar content being viewed by others
References
Djukanovic, R., Roche, W. R., Wilson, J. W., Beasley, C. W., Twentyman, O. P., Howarth, P. H., and Holgate, St. (1990),Am. Rev. Respir. Dis. 142, 434–457.
Busse, W. W. and Reed, C. (1988),Asthma Definition and Pathogenesis in Allergy Principles and Practice (Middleton, E., Jr., Reed, C., Ellis, E., Adkinson, F., Jr., and Yunginger, J. E., eds.), vol. II, 3rd Ed., C. S. Mosby, St. Louis, p. 969.
Hudgel, D. W., Langston, L., Seiner, J. C., and McIntosh, K. (1979),Am. Rev. Respir. Dis. 120, 393.
McIntosh, K., Ellis, E. F., Hoffman, L. S., Lybass, T. C., Eller, J. J. and Fulginiti, V. A. (1973),J. Pediatr. 82, 578.
Slavin, R. G. (1982),Ann. Allergy 49, 76.
Thomas, W. V. (1929),J. Allergy 1, 86.
Racheman, F. M. (1940),J. Allergy 11, 147.
Welliver, R. C., Wong, D. T., Sun, M., Middleton, E., Jr., Vaughan, R. S., and Ogra, P. L. (1981),N. Engl. J. Med. 305, 841–846.
Skoner, D. P., Page, R., Asman, B., Gitlin, L., and Fireman, P. (1988),Am. Rev. Respir. Dis. 137, 1009–1014.
Lin, M. C., Bleecker, E. R., Lichtenstein, L. M., Kagey-Sobot, K. A., Nu, Y., McLemore, T. L., Perlmitt, S., Proud, D., and Hubbard, W. C. (1990),Am. Rev. Respir. Dis. 142, 126–132.
Lemanske, R. F., Dick, E. C., Swenson, C. A., Vrtis, R. F., and Busse, W. W. (1989),J. Clin. Invest. 83, 1–10.
Busse, W. W., Swenson, C. A., Borden, E. C., Treuhaft, M. W., and Dick, E. C. (1983),J. Allergy Clin. Immunol. 71, 382–388.
Peter, G., ed.Influenza. Report of the Committee on Infectious Disease, American Acad. of Ped. (1988), Elk Grove Village, IL, 21st Ed., pp. 243–250.
Rachelefsky, G. S., Katz, R. M., and Siegel, S. C. (1984),Pediatrics 73, 526.
Friedman, R., Ackerman, M., Wald, E., Casselbrant, M., Friday, G., and Fireman, P. (1984),J. Allergy Clin. Immunol. 74, 185–195.
Friedman, W. H. and Slavin, R. G. (1984),Clin. Rev. Allergy 2, 409.
Bernton, H. A. (1957),South. Med. J. 50, 934–948.
Friedlaender, S., Friedlaender, A., and Werner, W. (1959),Am. J. Med. Sci. 238, 18–24.
Abernathy, R., Strem, E., and Good, R. (1958),Pediatr. 21, 980–993.
Fontana, V. (1963),J. Pediatr. 62, 80–84.
Mazer, B. D. and Gelfand, E. W. (1991),J. Allergy Clin. Immunol. 87, 976–983.
Mazer, B., Giclas, P., and Gelfand, E. (1989),Clin. Immunol. Immunopath. 53, S156-S163.
Buckley, R. H. (1987),JAMA 258, 2841–2849.
Schur, P., Borel, H., Gelfand, E., Alper, E., and Rosen, F. (1970),N. Engl. J. Med. 283, 631–634.
Bjorkander, J., Bake, B., Oxelius, V. A., and Hanson, L. (1985),N. EngL J. Med. 313, 720–724.
Shackelford, P., Polmar, S., Mayus, J., Johnson, W., Corry, J., and Nohm, M. (1986),J. Pediatr. 108, 647–653.
Smith, T. F., Ireland, T. A., Zaateri, G. S., Gay, E. B., Zwiren, G. T., and Andrews, H. G. (1985),AJDC 139, 1039–1044.
Smith, T. F., Morris, E. C., and Baron, F. P. (1984),J. Pediatr. 105, 896–900.
Umetsu, D. T., Ambrosino, D. M., Quinti, E., Siber, G. R., and Geha, R. S. (1985),N. Engl. J. Med. 313, 1247–1251.
Oxelius, V. A., Hansen, L., Bjorkander, J., Hammerstrim. L., Sjoholm, A. (1986),Monogr. Allergy 20, 106–115.
Bernatowska-Matuskiewicz, E., Poe, M., Skopczynska, H., Pum, M., and Eibl, M. M. (1991),Progress in Immune Deficiency (Chopel, H. M., Levinsky, R. J., and Webster, A. D. B., eds.), Royal Society of Medicine, London, pp. 45–52.
Loftus, B. G., Price, J. F., Lobo-Yeo, A., and Vergani, D.Arch. Dis. Child. 63, 1434–1437.
Page, R., Friday, G., Stillwagon, P., Skoner, D., Caliguiri, L., and Fireman, P. (1988),J. Pediatr. 112, 126–131.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fireman, P., Friday, G. Asthma. Clinical Reviews in Allergy 10, 135–142 (1992). https://doi.org/10.1007/BF02914376
Issue Date:
DOI: https://doi.org/10.1007/BF02914376